SI1423126T1 - Terapija hiperproliferativnih stanj na telesnih povrsinah - Google Patents

Terapija hiperproliferativnih stanj na telesnih povrsinah

Info

Publication number
SI1423126T1
SI1423126T1 SI200230607T SI200230607T SI1423126T1 SI 1423126 T1 SI1423126 T1 SI 1423126T1 SI 200230607 T SI200230607 T SI 200230607T SI 200230607 T SI200230607 T SI 200230607T SI 1423126 T1 SI1423126 T1 SI 1423126T1
Authority
SI
Slovenia
Prior art keywords
treatment
body surfaces
hyperproliferative conditions
psoriasis
relates
Prior art date
Application number
SI200230607T
Other languages
English (en)
Inventor
Thomas Broe Christensen
Bjarne Bymose
Original Assignee
Valderm Aps C O Elisabeth De D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valderm Aps C O Elisabeth De D filed Critical Valderm Aps C O Elisabeth De D
Publication of SI1423126T1 publication Critical patent/SI1423126T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
SI200230607T 2001-08-14 2002-08-12 Terapija hiperproliferativnih stanj na telesnih povrsinah SI1423126T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200101218 2001-08-14
EP02754556A EP1423126B1 (en) 2001-08-14 2002-08-12 Treatment of hyperproliferative conditions of body surfaces
PCT/DK2002/000530 WO2003015759A2 (en) 2001-08-14 2002-08-12 Treatment of hyperproliferative conditions of body surfaces

Publications (1)

Publication Number Publication Date
SI1423126T1 true SI1423126T1 (sl) 2008-02-29

Family

ID=8160668

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200230607T SI1423126T1 (sl) 2001-08-14 2002-08-12 Terapija hiperproliferativnih stanj na telesnih povrsinah

Country Status (13)

Country Link
US (2) US7345023B2 (sl)
EP (1) EP1423126B1 (sl)
JP (1) JP4361789B2 (sl)
AT (1) ATE371458T1 (sl)
AU (1) AU2002320964B2 (sl)
CY (1) CY1107814T1 (sl)
DE (1) DE60222144T2 (sl)
DK (1) DK1423126T3 (sl)
ES (1) ES2292789T3 (sl)
NZ (1) NZ531408A (sl)
PT (1) PT1423126E (sl)
SI (1) SI1423126T1 (sl)
WO (1) WO2003015759A2 (sl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011006504A2 (en) 2009-07-17 2011-01-20 Valderm Aps Treatment of hyperproliferative conditions
WO2013026454A1 (en) 2011-08-22 2013-02-28 Valderm Aps Treatment of clinical conditions with anthracyclines
JP6659735B2 (ja) 2015-07-10 2020-03-04 インフェクトファーム・アルツナイミッテル・ウント・コンシリウム・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 日光角化症の治療における水酸化カリウムの使用
CN108098458B (zh) * 2017-08-09 2019-12-24 徐先顺 一种用于抗hpv6/11的凝胶剂

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5149710A (en) * 1985-04-01 1992-09-22 National Research Development Corporation Pharmaceutical compositions for treating psoriasis
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
US4946683A (en) * 1987-11-18 1990-08-07 Vestar, Inc. Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes
AU3554089A (en) * 1988-04-27 1989-11-24 Yale University Compositions and methods for treating cutaneous hyperproliferative disorders
US6231855B1 (en) * 1991-03-12 2001-05-15 Istituto Nazionale Per Lo Studio E La Cura Dei Tumori Monoclonal antibodies as antidotes for anthracycline antibiotics
JP3251735B2 (ja) * 1992-09-25 2002-01-28 株式会社東芝 半導体集積回路装置
US5396195A (en) * 1993-12-13 1995-03-07 At&T Corp. Low-power-dissipation CMOS oscillator circuits
US6190691B1 (en) * 1994-04-12 2001-02-20 Adolor Corporation Methods for treating inflammatory conditions
US5900763A (en) * 1994-10-11 1999-05-04 Motorola, Inc. Circuit and method of reducing cross-talk in an integrated circuit substrate
ES2227536T3 (es) * 1995-06-27 2005-04-01 Pharmachemie B.V. Nuevos profarmacos de antraciclina, procedimiento de preparacion asi como su uso en quimioterapia selectiva.
DE19720312A1 (de) * 1997-05-15 1998-11-19 Hoechst Ag Zubereitung mit erhöhter in vivo Verträglichkeit
US5776915A (en) * 1997-08-12 1998-07-07 Clarion Pharmaceuticals Inc. Phosphocholines of retinoids
AU3764099A (en) 1998-04-28 1999-11-16 Tao Chen Polyanionic polymers which enhance fusogenicity
CA2331620A1 (en) 1998-05-11 1999-11-18 The Endowment For Research In Human Biology, Inc. Use of neomycin for treating angiogenesis-related diseases
AU778910B2 (en) * 1999-03-19 2004-12-23 Houston Pharmaceuticals, Inc. Methods and compositions for the manufacture of C-3' and C-4' anthracycline antibiotics
JP2001345428A (ja) * 2000-03-27 2001-12-14 Toshiba Corp 半導体装置とその製造方法
US6555095B1 (en) * 2001-12-14 2003-04-29 Avon Products, Inc. Topical compositions and methods of application

Also Published As

Publication number Publication date
EP1423126B1 (en) 2007-08-29
ES2292789T3 (es) 2008-03-16
DE60222144D1 (de) 2007-10-11
US7345023B2 (en) 2008-03-18
US20040242507A1 (en) 2004-12-02
US8263567B2 (en) 2012-09-11
WO2003015759A2 (en) 2003-02-27
DE60222144T2 (de) 2008-05-15
EP1423126A2 (en) 2004-06-02
JP2005504765A (ja) 2005-02-17
NZ531408A (en) 2005-07-29
JP4361789B2 (ja) 2009-11-11
US20080119546A1 (en) 2008-05-22
ATE371458T1 (de) 2007-09-15
CY1107814T1 (el) 2013-06-19
WO2003015759A3 (en) 2004-03-04
AU2002320964B2 (en) 2008-03-13
DK1423126T3 (da) 2008-02-04
PT1423126E (pt) 2007-12-07

Similar Documents

Publication Publication Date Title
WO2003055878A8 (de) 2-heteroarylcarbonsäureamide
WO2003018619A3 (en) Antimicrobial and anti-inflammatory peptides
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
GB0309765D0 (en) A cosmetic or dermopharmaceutical composition comprising an enzyme which is insoluble in an aqueous medium, as well as its uses.
CY1106628T1 (el) Τοπικες φαρμακευτικες συνθεσεις περιλαμβανουσες προανθοκυανιδινες, γλυκυρροχητινικο οξυ και τελμεστεϊνη για τη θεραπεια των δερματιτιδων
YU31801A (sh) Amidi antranilne kiseline i njihova upotreba kao leka
WO2003005979A3 (de) Osmolyte enhaltende kosmetische und dermatologische zubereitungen zur behandlung und aktiven prävention trockener haut und anderer negativer veränderungen der physiologischen homöostase der gesunden haut
HK1087398A1 (en) 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
HK1050899A1 (en) Pteridine compounds for the treatment of psoriasis
BR0009480A (pt) Soluções de poliuretano com unidades de estrutura de alcoxissilano
MXPA04003796A (es) Tioacetamidas sustituidas.
MXPA02011288A (es) Tioacetamidas substituidas.
AU2002248384A1 (en) Serpin drugs for treatment of hiv infection and method of use thereof
CA2436540A1 (en) Pharmaceutical compositions based on anticholinergics and corticosteroids
UA86399C2 (ru) Применение 2,5 дигидроксибензолсульфоновой кислоты для изготовления лекарства, которые применяют для лечения болезней, зависимых от ангиогенеза
CA2157836A1 (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
BR0209541A (pt) Uso das imidazotriazinonas 2-fenil-substituìdas
CY1107814T1 (el) Θεραπεια παθησεων υπερπολλαπλασιασμου των επιφανειων του σωματος
WO2000030660A3 (de) Hyperforin als zytostatikum sowie hyperforin-salbe oder -creme als applikationsform
BG101126A (en) The use of muramylpeptide compounds
WO2008050157A3 (en) Ozonated oil formulations
AR030945A1 (es) Amidas de acido fenilciclohexanocarboxilico sustituido y su uso
WO2002070537A3 (en) Fusidic acid derivatives
DOP2002000472A (es) Amidas de acido piperazinciclohexanocarboxilico sustituidas y su utilizacion.
MY169533A (en) Use of azithromycin for the manufacture of a medicament for treating ocular infections